Comparison of two iodine-125 brachytherapy implant techniques for the treatment of lung tumor: Preplanning and intraoperative planning.
To compare preplanning and intraoperative planning methods of lung tumor brachytherapy based on postimplant CT images and dosimetric outcomes. Detailed postimplant evaluations of iodine-125 seed implants were performed in 15 patients using a preplanning technique and in 15 patients treated with an intraoperative planning technique. The implant details, dosimetric parameters, and implant quality indices were compared. Furthermore, the dose to the lung and the incidence of complications were compared. The planning target volume was similar in both groups (p = 0.496). The median V100%, V150%, and V200% values (the percent of the planning target volume receiving 100%, 150%, and 200% of the prescription dose) for the intraoperative planning technique were 95.65%, 76.47%, and 59.80%, respectively. The median V100%, V150%, and V200% values for the preplanning methodology were 88.86%, 69.23%, and 28.30%, respectively (p < 0.01). The median values of the coverage index, c1, conformity index, and plan quality index were higher in the intraoperative planning group than in the preplanning group (p < 0.05). The overdose volume index and dose nonhomogeneity ratio were higher in the intraoperative group (p < 0.05), and the dose homogeneity index was lower in the intraoperative group (p < 0.05) than in the preplanning group. No significant differences were observed in the reference dose (VREF), external index, or lung doses between the two groups. The incidences of pneumothorax and hemoptysis were minimal in both groups. These data showed that the intraoperative planning method was superior to the preplanning method for the treatment of lung tumors.